Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles.
about
Bio-functionalized magnetic nanoparticles for the immunoassay of fetal fibronectin: a feasibility study for the prediction of preterm birth.Plasma α-synuclein predicts cognitive decline in Parkinson's disease.Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.Plasma Biomarkers Differentiate Parkinson's Disease From Atypical Parkinsonism Syndromes.The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer's Disease.Magnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review
P2860
Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Development of an ultra-high s ...... alized magnetic nanoparticles.
@en
type
label
Development of an ultra-high s ...... alized magnetic nanoparticles.
@en
prefLabel
Development of an ultra-high s ...... alized magnetic nanoparticles.
@en
P2093
P2860
P50
P921
P1476
Development of an ultra-high s ...... alized magnetic nanoparticles.
@en
P2093
Bing-Hsien Liu
Che-Chuan Yang
Herng-Er Horng
Hsin-Hsien Chen
Shieh-Yueh Yang
P2860
P2888
P356
10.1186/S12951-016-0198-5
P577
2016-06-08T00:00:00Z
P6179
1014729026